摘要
目的 :分析艾迪注射液联合FDH方案化疗 (观察组 )与单纯FDH方案化疗 (对照组 )对晚期胃癌的疗效、副反应及对免疫功能的影响。方法 :观察组 36例晚期胃癌患者在采用FDH方案化疗同期加用艾迪注射液 ,对照组 30例晚期胃癌患者单用FDH方案治疗。结果 :观察组有效率为 38 9% ,高于对照组 30 % ,但差异无显著性 (P >0 0 5 )。观察组治疗前后免疫功能的改变、副反应、胃肠反应均明显低于对照组 ,差异有显著性 (P <0 0 5 )。结论 :艾迪联合FDH方案治疗晚期胃癌 ,疗效显著 ,并降低了FDH化疗方案对免疫功能、胃肠道的影响及副反应。
Objective: To study the efficacy and the influence on immunological function of combination with AD and chemotherapy for advanced gastric carcinoma Methods: Group A(36 cases) were treated with AD injection and chemotherapy protocol of FDH, and group B(30 cases) were treated only with chemotherapy protocol of FDH Results: The effective rat of group A was higher than group B And the changes of immunological function, side effects, gastrointestinal response of group A were obviously lower than those of group B( P <0 05) Conclusion: Patients with AD injection and chemotherapy protocol of FDH had significant lower influence than those with only chemotherapy protocol of FDH The curative effect of AD injection and chemotherapy protocol of FDH were significant
出处
《广州医药》
2002年第5期39-40,共2页
Guangzhou Medical Journal
